This comparative study analyses the domestic market of domiciliary oxygen t
herapy in five European countries (Denmark, France, Germany, Italy, and the
UK) according to a common checklist of subjects. Domestic legislation, pre
scription procedures, delivery, and the market situation concerning oxygen
therapy were considered. The analysis involved (i) reviewing the literature
on oxygen therapy in national and international journals, and (ii) intervi
ewing a selected expert panel of market operators in each country (composed
of at least one civil servant, one physician, one distributor, and one oxy
gen manufacturer). The analysis did not find any specific relationship betw
een the health care system framework and the oxygen therapy market, except
for a greater inclination towards home care in national health services. In
all these countries oxygen therapy is reimbursed, but the type of supply a
nd its diffusion differ widely. The spread of domiciliary care has undermin
ed the traditional role of pharmacies in the oxygen distribution chain in a
ll countries except Italy. The study did not help identify any specific cou
ntry that can be considered a benchmark for oxygen therapy, each one dealin
g with oxygen therapy in a different way. An economic evaluation of the dif
ferent supply modalities could help improve decision making by public autho
rities. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.